Clinical Trial Update: Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating zidovudine, interferon alfa-2b, and PEG-interferon alfa-2b in HTLV-I-associated adult T-cell leukemia/lymphoma was terminated with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Leukemia Lymphoma

Drugs mentioned

• Interferon alfa-2b (interferon alfa-2b)
• PEG-Interferon alfa-2b (pegylated interferon alfa-2b)
• Zidovudine (Zidovudine)

Snippet

Sponsor: University of Miami | Conditions: Lymphoma, Precancerous/Nonmalignant Condition | Phase 4 | Status: TERMINATED | Results posted: 2015-01-06